Biggest News Aggregation in the World
📰 Rom News

Page 352 - Rom News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.

Oncolytics Biotech® Inc.: Oncolytics Biotech® Announces Updated Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial that Show Pelareorep Driving Robust Increases in Progression-Free Survival and Confirmed Overall Response Rate

Pelareorep-paclitaxel combination reduced risk of disease progression by 71% (hazard ratio of 0.29) compared to paclitaxel monotherapy 37.5% confirmed overall response rate with pelareorep-paclitaxel
United States Comunidad Autonoma De Cataluna Mecklenburg Vorpommern Bruxelles Capitale Timothy Mccarthy Aleix Prat

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

CatalYm Announces Initial Data from Ongoing Phase 2a Trial Evaluating GDF-15-targeting Antibody Visugromab in Combination with Nivolumab at ASCO 2023

Oral presentation highlights first data from the GDFATHER-2a trial demonstrating lasting and confirmed responses (as per RECIST criteria) following treatment with visugromab and the anti-PD-1 inhibitor
Mecklenburg Vorpommern United States Phil Lhuilier Ignacio Melero Bermejo Phil Lhuillier Stefan Klotter

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science